Aca 2013 Abstract Export Plenary Session: Plenary Session 1: Novel aspect of therapeutics of autoimmune diseases


Poster Session: Session 2: Sjogren's syndrome



Download 1.13 Mb.
Page16/19
Date19.10.2016
Size1.13 Mb.
#4941
1   ...   11   12   13   14   15   16   17   18   19

Poster Session: Session 2: Sjogren's syndrome

P2-017 CUTANEUS MANIFESTATION IN SJOGREN SYNDROME PATIENT TREATED WITH HYDROXYCLOROQUINE
D. Mulya1, N. Sukmana2


1Internal Medicine, Gadjah Mada University, Yogyakarta, Indonesia
2Allergy and Clinical Immunology, University of Indonesia, Jakarta, Indonesia

Introduction:

Sjogren Syndrome is frequent autoimmune disorder (prevalence 0,5% - 2%) characterized by lymphocyte infiltration of the salivary and lacrimal glands lead to dry eyes and mouth. Cutaneus skin manifestations in Sjogren Syndrome are often underestimated, whilst 50% of Sjogren syndrome have cutaneus finding. This condition made patients with Sjogren are wrongly diagnose nor had appropriate treatment earlier.

Case Presentation:

A 44 years old woman comes to our hospital with redness in her cheek since three years ago. She also felt pain in her skin and getting worse every time she got exposure from the sun. Patient also complained for headache and myalgia. From her physical examination we found malar rash and dry skin. The laboratory test showed positive Anti Nuclear Antibody, dsDNA was 13,8 , SS A +++, and Anti RO S2 ++. We also checked for her schirmer test and the result was 5 mm for right eye and 10 mm for left eye. Patients was treated with Hidroxychloroquine , Methylprednisolone 0,5 mg/Kg body weight, Vit D3, and Folic Acid. After one month therapy, patient showed improvement in her skin manifestation and she no longer feel pain in her skin.

Conclusion:

We treated a 44 years old women with cutaneus manifestation as a symptom of Sjogren syndrome. Patients was showed improvement while treated with Hidroxychloroquine , Methylprednisolone 0,5 mg/Kg body weight, Vit D3, and Folic Acid.
P2-018 PRIMARY SJOGREN’S SYNDROME PRESENTING WITH PERICARDIAL AND PLEURAL EFFUSION
V. Selvan1, S. Xu1


1Medicine, Khoo Teck Puat Hospital, Singapore, Singapore

Introduction

SjogrenÕs syndrome (SS) is a systemic autoimmune disease characterized by sicca symptoms. However, they are rarely accompanied

by serositis such as pleuritis or pericarditis. We present a case report of a primary SjogrenÕs syndrome presenting with pericardial and pleural effusion.

Case Report

The patient is a 50 year old Chinese female who was previously well. She presented with complaints of pleuritic chest pain, cough, fever and shortness of breath for 7 days. Physical examination revealed decreased breaths sounds in left lung base. She had a papulo-squamous lesion on her arm and leg. Chest xray showed bilateral pleural effusions and & cardiomegaly. ECG showed small voltages with non-specific T wave changes. CT scan of thorax and abdomen confirmed the presence of pericardial & pleural effusions. In addition there were mediastinal, axillary & supraclavicular lymphadenopathy.

Blood investigations showed anemia of 9.8gm/dL, ESR 59 mm/1st hr, CRP 66 mg/L. Pleural fluid analysis showed exudative effusion which was negative for malignancy and infection. T-spot was negative. On direct questioning, the patient admitted to a long history of dry eyes and dry mouth. Opthalmological review confirmed presence of keratoconjunctivitis sicca. Tests for ANA (+), Anti Ro (+), Anti La (+), ds DNA (-), Rheumatoid Factor (+). Tests for other ENA (-). She declined labial gland biopsy.

Primary SjogrenÕs syndrome was diagnosed based on the sicca symptoms, positive Ro and La but negative dsDNA.The patient was treated with steroids and Hydroxychloroquine with improvement.

SjogrenÕs Syndrome should be considered as one of the connective tissue diseases potentially presenting with pleural and pericardial effusion. This has been reported by other authors. http://abstract-aca13.kenes.com/aca13/cm.net.webui/abstracts/aca13/26312/skin.jpghttp://abstract-aca13.kenes.com/aca13/cm.net.webui/abstracts/aca13/26312/ct%20thorax.pnghttp://abstract-aca13.kenes.com/aca13/cm.net.webui/abstracts/aca13/26312/cxr.png
P2-019 THE IMPROVEMENT OF THE SURGICAL DENTAL CARE FOR PATIENTS WITH SJOEGREN'S DIS EASE
E. Selifanova1, E. Selifanova1


1Stomatology, Mental Health Research Center of RAMS, Moscow, Russia

Abstract:



There for, the purpose of this research is the improvement of organization of surgical dental care for patients with SD. The evaluation of the nec essity of the surgical sanation was based on the following criteria: the ext ent of the tooth crown destruction, tooth mobility, tooth retention and half -retention, tooth disposition, complicated with inflammation. The surgical manipulations included tooth extraction, cystectomy, cystotomy, periosteototy and the operations on the maxillary sinus. The therapy of the main disease and the focuses of odontogenic infection worsened the poor regeneration of the operative site among the patients with SD, this manifestation is espe cially good represented in cases f tooth extraction. The tooth sockets weren 't awfully filled with blood clot and postoperative healing required nearly 3 weeks among 85% of patients. In 80% of cases postoperative alveolitis was presented, and the slowly progressing osteomielitis was found among 35% of p atients. All the mentioned pathological processes required additional common and local therapy. The poor condition of sutures on the 3d day of postopera tive period was evaluated in 70% of cases. We recommend to make surgical sa nation of oral cavity among patients with SD after cancel of cytostatic ther apy and intensifying of non-steroid therapy. Also we recommend to prescribe the osteotrophic antibiotic therapy for 7 days and start it 2 before the ope ration and to prescribe antimicotic therapy in order to prevent further complications.
P2-020 EXOCRINOPATHY MEDIATED BY ANTIMUSCARINIC AUTOANTIBODIES IN SJÖGREN’S SYNDROME PATIENTS
K. Park1, M. Jin1, M. Park1, E. Namkoong1, S. Choi1


1Physiology, School of Dentistry SNU, Seoul, Korea

Background and aims : Recently, functional autoantibodies against to muscarinic type 3 receptor (M3R) in Sj*grenÕs syndrome (SS) has been reported. However, the pathological role of these autoantibodies in the development of SS still remains to be elucidated. Methods: Purified IgGs were obtained from normal (control) and primary SS patients' sera (pSS IgG). Anti-M3R autoantibodies in purified IgG were detected by M3R peptides using ELISA assay kit. Surface expression and internalization of M3R and MHC I molecules were analyzed by immunofluorescence confocal microscopy and biotinylation assay. Results: pSS IgG showed significantly higher arbitrary units (AU) values in C2M3RP and C4M3RP than the other 3 peptide groups (one way ANOVA, P<0.05). Surface expression of M3R, MHC I molecules but not β1AR was significantly decreased after incubation of human SMG cells with pSS IgG. Internalization of colocalized M3R and MHC I molecules from the cell surface to the cell interior during pSS IgG incubation was observed in hSMG cells and GFP·M3R transfected HSG cell line. Interaction of M3R and MHC I molecules at the plasma membrane increased after incubation with pSS IgG but not control IgG. The pSS IgG-induced M3R and MHC I internalization is prevented by the cholesterol-sequestering drug, filipin. Conclusion: Cholesterol-rich microdomain of the plasma membrane containing M3R and MHC I molecules was endocytosed by incubation of the cells with pSS IgG, which may partly explain the mechanism of exocrinopathy shown in primary SS patients.
P2-021 ASSOCIATION BETWEEN HIGH CIRCULATING LEVELS OF INTERLEUKIN-18 AND DISEASE ACTIVITY IN PRIMARY SJÖGREN'S SYNDROME
Y. Chen1, J.F. Zheng1, J.P. Yin1, R.L. Huang1, X. Gao2, X.H. Yu1, Z.G. Liu3, J. Chen4


1Medical College Xiamen University, Xiamen University, Xiamen, China
2Clinical Laboratory Department, Xiamen University Hospital, Xiamen, China
3Eye Institute and Affiliated Xiamen Eye Center of Xiamen University, Xiamen University, Xiamen, China
4Rheumatology Department, the First Afflicted Hospital of Xiamen University, Xiamen, China

Background and aims:


Interleukin-18 is a proinflammatory cytokine which plays an important role in infection, inflammation and autoimmunity. Previous studies show elevated levels of IL-18 in primary Sj*gren's syndrome, an autoimmune disease characterized by chronic inflammation in exocrine glands. We aimed to investigate the association between the levels of IL-18, sIL-18R1 and IL-18BP and pSS and its subphenotypes.
Methods:Thirty-five well-characterized pSS patients and matched controls were recruited in this study. The serum levels of IL-18, sIL-18R1 and IL-18BP were quantified using sandwich ELISA.
Results:Our results showed the levels of IL-18, but not IL-18BP or sIL-18R1 is higher in pSS patients than in controls (119.73±100.06 pg/mL vs 65.03 ± 45.70 pg/mL, P<0.01). Furthermore, the levels of IL-18 in patients with active disease are significantly higher than in patients with mildly active diseases (166.12±120.20 pg/mL vs 80.66 ±57.86pg/mL, ,P<0.01).
Conclusions:To our knowledge, this is the first study that shows an association between IL-18 levels and the disease activity of pSS. Our findings suggest that the circulating levels of IL-18 could be a biomarker indicating the disease activity of pSS and IL-18 may be a potential therapeutic target.
Figure 1
http://abstract-aca13.kenes.com/aca13/cm.net.webui/abstracts/aca13/32294/newfolder/figure%201.jpg
Figure 2
http://abstract-aca13.kenes.com/aca13/cm.net.webui/abstracts/aca13/32294/newfolder/layout%20figure2.jpg







group

IL-18(pg/mL)

IL-181(pg/mL)

IL-18BP(ng/mL)

Free IL-18(pg/mL)

pSS (n= 35)

119.73±100.06§

28.57% (10/35) a*



310.53±160.00

11.43% (4/35)a



21.11±10.79

20% (7/35)a



31.90±28.25§

20% (7/35)a*



Control (n=35 )

65.03±45.70

5.71% (2/35)a



262.89±123.18

2.86% (1/35)a



20.33±4.44

5.71% (2/35)a



16.83±12.31

2.86% (1/35)a



§Compared with healthy controls, P<0.01,by Mann-Whitney Test,

a Compared with healthy controls,P<0.05, by Fisher's exact Test.

Poster Session: Session 2: Skin and Autoimmunity

P2-022 INFLAMMATORY RESPONSES IN NONDERMATOMAL VITILIGO - A STUDY FROM SOUTH INDIA
Y. Ala1, M. Khalid Pasha1, V. Vijaya Lakshmi2, P. Jahan1


1Genetics, University college of Science Osmania University, Hyderabad, India
2Immunology and Molecular Biology, Lepra India-Blue Peter Public Health and Research Centre, Hyderabad, India

Background: Cytokines are the important mediators of immunity and disequilibrium in cytokine network may paramount for autoimmune disease susceptibility and severity. Vitiligo is an acquired depigmenting disorder resulting in the destruction of melanocytes in the epidermis affecting 1-4% worldwide with no prediction for sex or race. The incidence of vitiligo is found to be 0.5 to 2.5% in India. The cause of vitiligo remains obscure, although the autoimmune hypothesis has been now recognized as the most influential pathogenic mechanism. The present study was conducted to determine the equilibrium between two important cytokines IFN-γ and IL-10 in nondermatomal vitiligo and healthy individuals from South India.

Aim: To estimate the serum levels of IFN-γ and IL-10 in nondermatomal vitiligo patients and assess the ratio of these proinflammatory and anti-inflammatory cytokines with respect to disease duration.

Methods: Estimation of IFN-γ and IL-10 levels in human serum from each of 60 nondermatomal vitiligo patients and healthy controls using ELISA. Data analysis was performed using One-way ANOVA and t-test.

Results: Vitiligo patients showed increased levels of IFN- γ (11.7±5.2 vs 9.9±4.1 pg/ml) and decreased levels of IL-10 (9.4±5 vs 11.5±5.0 pg/ml) compared to controls. Ratio of IFN-γ to IL-10 was also significantly different in patients (1.5±0.7 pg/ml) and controls (1.0±0.6 pg/ml), indicating association of proinflammation with nondermatomal vitiligo. Further, significant correlation (p<0.05) was observed with disease duration.

Conclusion: Enhanced production of IFN-γ in patients may play a vital role in disease development suggesting Th1 mediated immune response in the pathogenesis of vitiligo.


P2-023 ASSOCIATION OF RAISED CAROTID INTIMA MEDIA THICKNESS WITH APOLIPOPROTEIN B/APOLIPOPROTEIN A-I IN PATIENTS OF PSORIASIS.
K. Asha1, A. Singal2, S.B. Sharma1, A. Aggarwal3


1Department of Biochemistry, University College of Medical Sciences, Delhi, India
2Department of Dermatology, University College of Medical Sciences, Delhi, India
3Department of Medicine, University College of Medical Sciences, Delhi, India

Background and aims: Psoriasis patients are at increased risk of cardiovascular diseases (CVD), including atherosclerosis. Carotid intima-media thickness (CIMT) has been recognized as a diagnostic tool to identify premature atherosclerosis. Studies have shown that apolipoprotein measurement can help in prediction of CVD, however association between apolipoprotein and CIMT need to be studied. The aim of this study was to measure CIMT and estimate its relationship with apoB/apoA-I ratio in patients of psoriasis.

Methods: Serum lipid profile and apolipoprotein (apoA-I and apoB) were measured, in all hundred psoriasis patients and age-sex matched healthy controls recruited for the study. Intima-media thickness and carotid plaques were simultaneously measured by carotid sonography.

Results: The apoB/apoA-I ratio ( P < 0.001) and serum apoB ( P < 0.05) significantly correlated with raised CIMT in patients. Conventional lipid profile and apoA-I levels were not correlated to IM thickness. By regression analysis we found that apoB/apoA-I ratio was associated with CIMT.

Conclusions: The study shows that apoB/apoA-I ratio is associated with raised intima-media thickness and can be considered as a predictor of sub-clinical atherosclerosis in patients of psoriasis.
P2-024 NEVIRAPINE INDUCED STEVENS JOHNSON SYNDROME
D. Madi1, C. Mahabala1, M.R. Pavan1


1Medicine, Manipal university, mangalore, India

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare immune mediated cutaneous adverse reactions. The basic difference between SJS and TEN is the percentage of body surface area (BSA) involved: <10% in SJS; >30% in TEN; 10 to 30% in SJS-TEN overlap. Drugs and infections commonly cause SJS. Nevirapine a non-nucleoside reverse transcriptase inhibitor (NNRTI), is widely prescribed in India as a part of the combination therapy to treat human immunodeficiency virus (HIV) infection. Nevirapine which is used to treat HIV can also cause SJS. Patients infected with human immunodeficiency virus are at increased risk of developing mucocutaneous drug reactions. We report a case of Nevirapine induced SJS.


A 47 year old gentleman,known case of HIV was started on Nevirapine based treatment as his CD4 cell count dropped to 342 cells/mm³. Sixteen days later he presented with a mild skin rash on the trunk, conjunctivitis and fever. Over the next few days the rashes became diffuse, bullous and progressed to involve the face, trunk and upper limbs (Figure 1). Nevirapine was discontinued.He was treated with steroids and antibiotics.He improved completely over next four weeks.
Although they are rare, these disorders have a high mortality rate. The most essential part of therapy is to discontinue use of the suspected drug
.http://abstract-aca13.kenes.com/aca13/cm.net.webui/abstracts/aca13/18836/07062012801%20(2).jpghttp://abstract-aca13.kenes.com/aca13/cm.net.webui/abstracts/aca13/18836/07062012801%20(2)_thumb.jpg
P2-025 CLINICAL PROFILE OF CHILDHOOD AUTOIMMUNE BLISTERING DISEASES OVER FIVE YEARS PERIOD FROM 2008 TO 2012
S.D. Shenoi1, R. Rao1


1Dermatology, Kasturba Medical College, Manipal, India

BACKGROUND AND AIMS

Autoimmune blistering diseases ( AIBD ) in children are uncommon and are due to circulating antibodies to either epidermal adhesion protein desmoglein or basement membrane zone components causing epidermal and subepidermal blisters respectively.Amongst AIBD,most common is linear IgA disease (LAD ).Pemphigus vulgaris(PV) pemphigus foliaceus( PF ),dermatitis herpetiformis ( DH )and bullous pemphigoid ( BP )rarely occur.The aim was to study incidence and clinical profile of AIBD in children over five years period from 2008 to 2012.

METHODS:


31 children aged below 18 years with suspected AIBD underwent direct immunofluorescence ( DIF ).13 (7 girls, 6 boys ) confirmed cases of AIBD aged between 2 and 17 years were evaluated in detail.

RESULTS:


There were 7 cases of LAD,5 cases of BP and 1 of PV but none of DH or PF.Duration of disease ranged from 1month to 3 years.All BP cases had oral involvement at presentation or during folowup while none of the LAD patients had oral lesions during the course of the disease.The cutaneous lesions consisting of tense blisters were indistinguishable in both BP and LAD.All LAD cases were treated with dapsone except one who developed anaemia to dapsone and was given steroids. BP cases were treated with oral steroids and dapsone was added in one.All patients improved with treatment except the patient with PV who expired following sepsis 10 days after admission.

CONCLUSION:

Direct immunofluorescence is the gold standard in the diagnosis of AIBD.Presence of oral lesions may be a marker of childhood BP.
P2-026 TREATMENT OF ALOPECIA AREATA UNIVERSALIS WITH DIALYZABLE LEUKOCYTE EXTRACTS, A REPORT OF 2 CASES.
T.A. Homberg1, M.C. Andaluz1, O. Pineda1, E. Cervantes1, M.A. Alonso1, M.C. Jimenez2, S.M. Pérez-Tapia1


1Immunology, Instituto Politécnico Nacional, Mexico City, Mexico
2Research Unit, I.A.P. Fundación Conde de Valenciana, Mexico City, Mexico

Alopecia areata is a T-lymphocyte mediated autoimmune disease of the hair follicle. Alopecia universalis is a severe form that affects hair in the entire body. Initial presentation is often related to physical or emotional stress. No specific treatment has proved successful on the long term. Although alopecia areata often presents spontaneous remission over a few months, persistent cases cause patients to seek experimental and alternative treatment. We present two cases of persistent alopecia areata universalis treated with dialyzable leucocyte extracts (DLE). Case 1 is a 4 year old girl with alopecia universalis since age 2, not responding to previous topical treatment or corticosteroids. After 3 weeks of treatment with DLE there is growth of eyebrows, eyelashes and scalp hair, continuing for 5 more months. Case 2 is a 38 year old female with alopecia universalis since age 34, with concomitant autoimmune hypothyroidism, not responding to different treatments including immunosupressants. She presents 70% improvement after 4 months of treatment with DLE.



Dialyzable leukocyte extracts are a human blood derived product composed of low molecular weight peptides ranging from 1 to 12kDa in size. The proposed mechanism of action is induction of a Th1 immune response, which makes it useful in the treatment of autoimmune disease. These cases represent a favorable response in severe and difficult to treat cases of alopecia areata. Nonetheless, the effects after 5 months have not been evaluated and a larger simple size is necessary to determine the effectiveness of DLE in this disease.
P2-027 EFFECTS OF ACUPOINT THERMAL STIMULATION ON ITCH IN THE MICE ATOPIC DERMATITIS MODEL
Y.H. Chen1, W.C. Chen1, H.Y. Chen1, K.S. Tsai2


1Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan
2Department of Dermatology, China Medical University Hospital, Taichung, Taiwan

Background and aims: Chinese ancient records and several clinic trials showed that acupuncture make a significant reduction of atopic dermatitis symptoms. We investigated the effects of different thermal stimulation at acupoint LI11 (Quchi) on scratching in mice elicited by subcutaneous administration of the pruritogenic agent (compound 48/80).

Methods: Ninety male ICR mice were divided into different groups: Normal saline s.c.; Compound 48/80 s.c.; and Compound 48/80 s.c. with various thermal (5¡C, 15¡C, 25¡C, 35¡C and 45¡C) stimulation at L111. The mice were acclimated individually in rectangular observation boxes for at least 2 hours. After different temperature stimulation (n = 6/condition) was performed at LI11 acupoint in mice under isoflurane anesthesia for 20 minutes, pruritogens were subcutaneous administrated on midline behind the neck of each mouse, and the scratch response was recorded. The other two groups without temperature stimulation were subcutaneous administrated of pruritogens or normal saline after anesthesia. Moreover, the cervical spinal cords (C5 - C7) were removed and fixed in paraformaldehyde solution overnight at 4ºC. Six cervical sections from each animal were randomly selected and the number of c-fos positive nuclei was counted under a light microscope.

Results: The application of lower temperature (15¡C) at the LI11 acupoint attenuated compound 48/80-induced scratch. In addition, the application of lower temperature to the LI11 acupoint also decreased the number of c-fos positive nuclei provoked by compound 48/80.

Conclusions: Lower temperature stimulation (15¡C) at the LI11 acupoint attenuated scratching behavior induced by compound 48/80 in the mice atopic dermatitis model.
Download 1.13 Mb.

Share with your friends:
1   ...   11   12   13   14   15   16   17   18   19




The database is protected by copyright ©ininet.org 2024
send message

    Main page